New Publication Validates SeptiCyte RAPID as a Triaging Tool for COVID-19 Patients

SEATTLE and BRISBANE, Australia, Feb. 2, 2023. Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the publication of a study in Scientific Reports, a journal in the...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials